Related Experiment Video
Updated: Jan 20, 2026

Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics
Published on: October 2, 2014
Andexanet Alfa: Preferred Treatment or Therapeutic Option?
Curtis A Blow1, Luke A Probst2, Christopher D Miller3
1PGY-1 Pharmacy Resident, Upstate University Hospital, Syracuse, New York.
No abstract available in PubMed .
Related Concept Videos
08:29Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics
04:11Endolymphatic Duct Blockage as a Surgical Treatment Option for Ménière's Disease
07:46In vivo Imaging and Therapeutic Treatments in an Orthotopic Mouse Model of Ovarian Cancer
06:40Operant Conditioning Task to Measure Song Preference in Zebra Finches
08:38A System for Tracking the Dynamics of Social Preference Behavior in Small Rodents
Therapeutic Index

